Latest period
$7.37B
YoY change
+5.8%
5Y CAGR
+1.2%
Peak year (2025)
$7.17B
Latest annual
$7.17B
Total Equity history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $7.17B
Total Equity growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +5.8%
Total Equity history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $7.17B | +5.8% | +$392.00M | ||
| 2024 | $6.78B | +7.5% | +$471.00M | ||
| 2023 | $6.31B | +7.0% | +$414.00M | ||
| 2022 | $5.89B | -8.6% | −$551.00M | ||
| 2021 | $6.44B | -4.7% | −$315.00M | ||
| 2020 | $6.76B | +19.8% | +$1.12B | ||
| 2019 | $5.64B | +8.1% | +$425.00M | ||
| 2018 | $5.22B | +6.0% | +$295.00M | ||
| 2017 | $4.92B | +6.3% | +$293.00M | ||
| 2016 | $4.63B | -1.2% | −$56.00M | ||
| 2015 | $4.68B | +8.9% | +$383.00M | ||
| 2014 | $4.30B | +8.9% | +$353.00M | ||
| 2013 | $3.95B | -5.2% | −$215.10M | ||
| 2012 | $4.16B | +12.7% | +$470.20M | ||
| 2011 | $3.69B | -8.4% | −$340.50M | ||
| 2010 | $4.03B | +1.1% | +$43.80M | ||
| 2009 | $3.99B | +10.7% | +$384.70M | ||
| 2008 | $3.60B | +8.4% | +$280.66M | ||
| 2007 | $3.32B | +10.1% | +$305.07M | ||
| 2006 | $3.02B | +9.3% | +$256.19M | ||
| 2005 | $2.76B | +20.7% | +$474.33M | ||
| 2004 | $2.29B | -4.4% | −$106.04M | ||
| 2003 | $2.39B | +35.4% | +$625.83M | ||
| 2002 | $1.77B | +32.4% | +$432.88M | ||
| 2001 | $1.34B | +29.5% | +$304.19M | ||
| 2000 | $1.03B | +19.5% | +$168.69M | ||
| 1999 | $863.10M | +52.0% | +$295.20M | ||
| 1998 | $567.90M | +4.8% | +$26.20M | ||
| 1997 | $541.70M | +0.6% | +$2.98M | ||
| 1996 | $538.72M | — | — |
- 2025$7.17B+5.8%
- 2024$6.78B+7.5%
- 2023$6.31B+7.0%
- 2022$5.89B-8.6%
- 2021$6.44B-4.7%
- 2020$6.76B+19.8%
- 2019$5.64B+8.1%
- 2018$5.22B+6.0%
- 2017$4.92B+6.3%
- 2016$4.63B-1.2%
- 2015$4.68B+8.9%
- 2014$4.30B+8.9%
- 2013$3.95B-5.2%
- 2012$4.16B+12.7%
- 2011$3.69B-8.4%
- 2010$4.03B+1.1%
- 2009$3.99B+10.7%
- 2008$3.60B+8.4%
- 2007$3.32B+10.1%
- 2006$3.02B+9.3%
- 2005$2.76B+20.7%
- 2004$2.29B-4.4%
- 2003$2.39B+35.4%
- 2002$1.77B+32.4%
- 2001$1.34B+29.5%
- 2000$1.03B+19.5%
- 1999$863.10M+52.0%
- 1998$567.90M+4.8%
- 1997$541.70M+0.6%
- 1996$538.72M—
Total Equity values are taken from Quest Diagnostics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's latest reported total equity is $7.37B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Quest Diagnostics (DGX) total equity is $7.17B – grew 5.8% year-over-year.
Quest Diagnostics total equity has grown for 3 consecutive years, with a +1.2% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak total equity at $7.17B, with the historical low of $538.72M recorded in 1996.
Quest Diagnostics Total Equity by Year
Quest Diagnostics Total Equity 2025: $7.17B
In 2025, Quest Diagnostics reported total equity of $7.17B, grew 5.8% from 2024. This figure represents the highest annual value in the available history.
Quest Diagnostics Total Equity 2024: $6.78B
Quest Diagnostics total equity in 2024 was $6.78B, grew 7.5% from 2023.
Quest Diagnostics Total Equity 2023: $6.31B
2023's total equity for Quest Diagnostics came in at $6.31B, grew 7.0% from 2022.
Quest Diagnostics Total Equity 2022: $5.89B
Quest Diagnostics posted total equity of $5.89B in 2022, declined 8.6% below 2021.
Quest Diagnostics Total Equity 2021: $6.44B
Quest Diagnostics total equity in 2021 was $6.44B.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Total Equity
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation